Liver fibrosis results from an excessive wound healing response in most chronic liver
diseases, such as hepatitis C. Despite great advances in antiviral therapy in recent years …

Living donor liver transplantation (LDLT) has emerged as an alternative to deceased donor
liver transplantation (DDLT) because of the increasing number of patients waiting for liver …

Hepatitis C virus (HCV) infection is a leading cause of liver transplantation and there is an
urgent need to develop therapies to reduce rates of HCV infection of transplanted livers …

With improved long-term survival following liver transplantation (LT), issues relating to the
assessment of the liver allograft in long-term survivors are becoming increasingly relevant …

Abstract Treatment of hepatocellular carcinoma (HCC) is guided by the tumour stage. The
Barcelona clinical liver cancer (BCLC) score endorsed by the European Society of the Liver …

The advent of safe and highly effective direct-acting antiviral agents (DAAs) has had huge
implications for the hepatitis C virus (HCV) transplant field, and changed our management of …

Rapid allograft infection complicates liver transplantation (LT) in patients with hepatitis C
virus (HCV). Pegylated interferon-α and ribavirin therapy after LT has significant toxicity and …

The management of hepatocellular carcinoma (HCC) is decided according to evidence‐
based recommendations generated by international societies: according to these …

Update in liver transplantation : Current Opinion in Gastroenterology Update in liver
transplantation : Current Opinion in Gastroenterology Log in or Register Subscribe to journalSubscribe …

Clinical outcomes of recurrent hepatitis C virus after liver transplantation are difficult to
predict. We evaluated collagen proportionate area (CPA), a quantitative histological index …